| Year |
Citation |
Score |
| 2019 |
Chitnis T, Glanz BI, Gonzalez C, Healy BC, Saraceno TJ, Sattarnezhad N, Diaz-Cruz C, Polgar-Turcsanyi M, Tummala S, Bakshi R, Bajaj VS, Ben-Shimol D, Bikhchandani N, Blocker AW, Burkart J, et al. Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosis. Npj Digital Medicine. 2: 123. PMID 31840094 DOI: 10.1038/s41746-019-0197-7 |
0.52 |
|
| 2019 |
Schubert RD, Hawes IA, Ramachandran PS, Ramesh A, Crawford ED, Pak JE, Wu W, Cheung CK, O'Donovan BD, Tato CM, Lyden A, Tan M, Sit R, Sowa GA, Sample HA, ... ... Chitnis T, et al. Pan-viral serology implicates enteroviruses in acute flaccid myelitis. Nature Medicine. PMID 31636453 DOI: 10.1038/s41591-019-0613-1 |
0.4 |
|
| 2019 |
Palotai M, Nazeri A, Cavallari M, Healy BC, Glanz B, Gold SM, Weiner HL, Chitnis T, Guttmann CRG. History of fatigue in multiple sclerosis is associated with grey matter atrophy. Scientific Reports. 9: 14781. PMID 31611598 DOI: 10.1038/s41598-019-51110-2 |
0.52 |
|
| 2019 |
Rezende RM, Nakagaki BN, Moreira TG, Lopes JR, Kuhn C, Tatematsu BK, Boulenouar S, Maghzi AH, Rubino S, Menezes GB, Chitnis T, Weiner HL. γδ T Cell-Secreted XCL1 Mediates Anti-CD3-Induced Oral Tolerance. Journal of Immunology (Baltimore, Md. : 1950). PMID 31578268 DOI: 10.4049/jimmunol.1900784 |
0.52 |
|
| 2019 |
Keyhanian K, Saxena S, Gombolay G, Healy BC, Misra M, Chitnis T. Adipokines are associated with pediatric multiple sclerosis risk and course. Multiple Sclerosis and Related Disorders. 36: 101384. PMID 31550559 DOI: 10.1016/j.msard.2019.101384 |
0.4 |
|
| 2019 |
Palotai M, Cavallari M, Koubiyr I, Morales Pinzon A, Nazeri A, Healy BC, Glanz B, Weiner HL, Chitnis T, Guttmann CR. Microstructural fronto-striatal and temporo-insular alterations are associated with fatigue in patients with multiple sclerosis independent of white matter lesion load and depression. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519869185. PMID 31418637 DOI: 10.1177/1352458519869185 |
0.52 |
|
| 2019 |
Yano H, Gonzalez C, Healy BC, Glanz BI, Weiner HL, Chitnis T. Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes. Multiple Sclerosis and Related Disorders. 35: 119-127. PMID 31374460 DOI: 10.1016/j.msard.2019.07.021 |
0.52 |
|
| 2019 |
Zurawski J, Glanz BI, Healy BC, Tauhid S, Khalid F, Chitnis T, Weiner HL, Bakshi R. The impact of cervical spinal cord atrophy on quality of life in multiple sclerosis. Journal of the Neurological Sciences. 403: 38-43. PMID 31207364 DOI: 10.1016/j.jns.2019.04.023 |
0.52 |
|
| 2019 |
Rosso M, Kimbrough DJ, Gonzalez CT, Glanz BI, Healy BC, Rocca MA, Filippi M, Weiner H, Chitnis T. Cross-sectional study of smoking exposure: no differential effect on OCT metrics in a cohort of MS patients. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 5: 2055217319828400. PMID 30828461 DOI: 10.1177/2055217319828400 |
0.4 |
|
| 2019 |
Zurawski J, Glanz BI, Chua A, Lokhande H, Rotstein D, Weiner H, Engler D, Chitnis T, Healy BC. Time between expanded disability status scale (EDSS) scores. Multiple Sclerosis and Related Disorders. 30: 98-103. PMID 30763908 DOI: 10.1016/j.msard.2019.02.007 |
0.4 |
|
| 2019 |
Hemond CC, Glanz BI, Bakshi R, Chitnis T, Healy BC. The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis. Bmc Neurology. 19: 23. PMID 30755165 DOI: 10.1186/s12883-019-1245-2 |
0.4 |
|
| 2018 |
Chitnis T, Gonzalez C, Healy BC, Saxena S, Rosso M, Barro C, Michalak Z, Paul A, Kivisakk P, Diaz-Cruz C, Sattarnezhad N, Pierre IV, Glanz BI, Tomic D, Kropshofer H, et al. Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis. Annals of Clinical and Translational Neurology. 5: 1478-1491. PMID 30564615 DOI: 10.1002/acn3.638 |
0.52 |
|
| 2018 |
Fakih R, Diaz-Cruz C, Chua AS, Gonzalez C, Healy BC, Sattarnezhad N, Glanz BI, Weiner HL, Chitnis T. Food allergies are associated with increased disease activity in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30563943 DOI: 10.1136/jnnp-2018-319301 |
0.52 |
|
| 2018 |
Healy BC, Zurawski J, Gonzalez CT, Chitnis T, Weiner HL, Glanz BI. Assessment of computer adaptive testing version of the Neuro-QOL for people with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518810159. PMID 30381985 DOI: 10.1177/1352458518810159 |
0.52 |
|
| 2018 |
Healy BC, Glanz BI, Zurawski JD, Mazzola M, Chitnis T, Weiner HL. Long-term follow-up for multiple sclerosis patients initially treated with interferon-beta and glatiramer acetate. Journal of the Neurological Sciences. 394: 127-131. PMID 30248571 DOI: 10.1016/j.jns.2018.09.020 |
0.52 |
|
| 2018 |
Dastagir A, Healy BC, Chua AS, Chitnis T, Weiner HL, Bakshi R, Tauhid S. Brain and spinal cord MRI lesions in primary progressive vs. relapsing-remitting multiple sclerosis. Eneurologicalsci. 12: 42-46. PMID 30229136 DOI: 10.1016/j.ensci.2018.07.002 |
0.52 |
|
| 2018 |
Regev K, Healy BC, Paul A, Diaz-Cruz C, Mazzola MA, Raheja R, Glanz BI, Kivisäkk P, Chitnis T, Jagodic M, Piehl F, Olsson T, Khademi M, Hauser S, Oksenberg J, et al. Identification of MS-specific serum miRNAs in an international multicenter study. Neurology(R) Neuroimmunology & Neuroinflammation. 5: e491. PMID 30175165 DOI: 10.1212/NXI.0000000000000491 |
0.6 |
|
| 2018 |
Khalid F, Healy BC, Dupuy SL, Chu R, Chitnis T, Bakshi R, Houtchens M. Quantitative MRI analysis of cerebral lesions and atrophy in post-partum patients with multiple sclerosis. Journal of the Neurological Sciences. 392: 94-99. PMID 30031994 DOI: 10.1016/j.jns.2018.06.025 |
0.4 |
|
| 2018 |
Leclaire K, Cecil A, LaRussa A, Stuart F, Hemond CC, Healy BC, Chitnis T, Weiner H, Huffman J, Glanz BI. A Pilot Study of a Group Positive Psychology Intervention for Patients with Multiple Sclerosis. International Journal of Ms Care. 20: 136-141. PMID 29896050 DOI: 10.7224/1537-2073.2017-002 |
0.4 |
|
| 2018 |
Raheja R, Regev K, Healy BC, Mazzola MA, Beynon V, von Glehn F, Paul A, Diaz-Cruz C, Gholipour T, Glanz BI, Kivisakk P, Chitnis T, Weiner HL, Berry JD, Gandhi R. Correlating serum microRNAs and clinical parameters in Amyotrophic lateral sclerosis. Muscle & Nerve. PMID 29466830 DOI: 10.1002/mus.26106 |
0.52 |
|
| 2018 |
Bove R, Healy BC, Musallam A, Soltany P, Diaz-Cruz C, Sattarnezhad N, Glanz BI, Kivisäkk P, Miller KK, Chitnis T. Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517750768. PMID 29320952 DOI: 10.1177/1352458517750768 |
0.4 |
|
| 2017 |
Cavallari M, Egorova S, Healy BC, Palotai M, Prieto JC, Polgar-Turcsanyi M, Tauhid S, Anderson M, Glanz B, Chitnis T, Guttmann CRG. Evaluating the Association between Enlarged Perivascular Spaces and Disease Worsening in Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 29226505 DOI: 10.1111/jon.12490 |
0.4 |
|
| 2017 |
Yousuf F, Dupuy SL, Tauhid S, Chu R, Kim G, Tummala S, Khalid F, Weiner HL, Chitnis T, Healy BC, Bakshi R. A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis. Journal of the Neurological Sciences. PMID 29146095 DOI: 10.1016/j.jns.2017.10.019 |
0.52 |
|
| 2017 |
Eagle T, Stuart F, Chua AS, LaRussa A, Leclaire K, Cook SL, Chitnis T, Weiner HL, Glanz BI, Healy BC. Treatment satisfaction across injectable, infusion, and oral disease-modifying therapies for multiple sclerosis. Multiple Sclerosis and Related Disorders. 18: 196-201. PMID 29141809 DOI: 10.1016/j.msard.2017.10.002 |
0.52 |
|
| 2017 |
Diaz-Cruz C, Chua AS, Malik MT, Kaplan T, Glanz BI, Egorova S, Guttmann CRG, Bakshi R, Weiner HL, Healy BC, Chitnis T. The effect of alcohol and red wine consumption on clinical and MRI outcomes in multiple sclerosis. Multiple Sclerosis and Related Disorders. 17: 47-53. PMID 29055473 DOI: 10.1016/j.msard.2017.06.011 |
0.52 |
|
| 2017 |
Chitnis T, Weiner HL. CNS inflammation and neurodegeneration. The Journal of Clinical Investigation. PMID 28872464 DOI: 10.1172/JCI90609 |
0.52 |
|
| 2017 |
Greeke EE, Chua AS, Healy BC, Rintell DJ, Chitnis T, Glanz BI. Depression and fatigue in patients with multiple sclerosis. Journal of the Neurological Sciences. 380: 236-241. PMID 28870578 DOI: 10.1016/j.jns.2017.07.047 |
0.4 |
|
| 2017 |
Bove R, Chitnis T, Cree BA, Tintoré M, Naegelin Y, Uitdehaag BM, Kappos L, Khoury SJ, Montalban X, Hauser SL, Weiner HL. SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517726657. PMID 28847219 DOI: 10.1177/1352458517726657 |
0.6 |
|
| 2017 |
Sattarnezhad N, Farrow S, Kimbrough D, Glanz B, Healy B, Chitnis T. Agreement analysis comparing iPad LCVA and Sloan testing in multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517713667. PMID 28585909 DOI: 10.1177/1352458517713667 |
0.52 |
|
| 2017 |
Zhao Y, Healy BC, Rotstein D, Guttmann CR, Bakshi R, Weiner HL, Brodley CE, Chitnis T. Exploration of machine learning techniques in predicting multiple sclerosis disease course. Plos One. 12: e0174866. PMID 28379999 DOI: 10.1371/journal.pone.0174866 |
0.52 |
|
| 2017 |
Healy BC, Buckle GJ, Ali EN, Egorova S, Khalid F, Tauhid S, Glanz BI, Chitnis T, Guttmann CR, Weiner HL, Bakshi R. Characterizing Clinical and MRI Dissociation in Patients with Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 28261936 DOI: 10.1111/jon.12433 |
0.52 |
|
| 2017 |
Bove R, Rankin K, Chua AS, Saraceno T, Sattarnezhad N, Greeke E, Stuart F, LaRussa A, Glanz BI, Chitnis T. Oral contraceptives and MS disease activity in a contemporary real-world cohort. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517692420. PMID 28155573 DOI: 10.1177/1352458517692420 |
0.32 |
|
| 2017 |
Regev K, Healy BC, Khalid F, Paul A, Chu R, Tauhid S, Tummala S, Diaz-Cruz C, Raheja R, Mazzola MA, von Glehn F, Kivisakk P, Dupuy SL, Kim G, Chitnis T, et al. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity. Jama Neurology. PMID 28114622 DOI: 10.1001/jamaneurol.2016.5197 |
0.52 |
|
| 2017 |
Kim G, Chu R, Yousuf F, Tauhid S, Stazzone L, Houtchens MK, Stankiewicz JM, Severson C, Kimbrough D, Quintana F, Chitnis T, Weiner HL, Healy BC, Bakshi R. Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis. The International Journal of Neuroscience. 1-34. PMID 28100092 DOI: 10.1080/00207454.2017.1283313 |
0.52 |
|
| 2016 |
Glanz BI, Greeke E, LaRussa A, Stuart F, Rintell DJ, Chitnis T, Healy BC. Risk attitudes and risk perceptions in individuals with multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2: 2055217316665406. PMID 28607735 DOI: 10.1177/2055217316665406 |
0.4 |
|
| 2016 |
Davoudi V, Keyhanian K, Bove RM, Chitnis T. Immunology of neuromyelitis optica during pregnancy. Neurology(R) Neuroimmunology & Neuroinflammation. 3: e288. PMID 27761482 DOI: 10.1212/NXI.0000000000000288 |
0.4 |
|
| 2016 |
Regev K, Paul A, Healy B, von Glenn F, Diaz-Cruz C, Gholipour T, Mazzola MA, Raheja R, Nejad P, Glanz BI, Kivisakk P, Chitnis T, Weiner HL, Gandhi R. Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis. Neurology® Neuroimmunology & Neuroinflammation. 3: e267. PMID 27606352 DOI: 10.1212/NXI.0000000000000267 |
0.52 |
|
| 2016 |
Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, Patel B, Mazzola MA, Liu S, Glanz BL, Cook S, Tankou S, Stuart F, Melo K, Nejad P, ... ... Chitnis T, et al. Alterations of the human gut microbiome in multiple sclerosis. Nature Communications. 7: 12015. PMID 27352007 DOI: 10.1038/ncomms12015 |
0.52 |
|
| 2016 |
McDonald J, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Lulu S, Ness J, Harris Y, Rubin J, ... ... Chitnis T, et al. A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. Multiple Sclerosis and Related Disorders. 6: 87-92. PMID 27063630 DOI: 10.1016/j.msard.2016.02.011 |
0.6 |
|
| 2016 |
Cavallari M, Palotai M, Glanz BI, Egorova S, Prieto JC, Healy BC, Chitnis T, Guttmann CR. Fatigue predicts disease worsening in relapsing-remitting multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26920374 DOI: 10.1177/1352458516635874 |
0.4 |
|
| 2015 |
Mazzola MA, Raheja R, Murugaiyan G, Rajabi H, Kumar D, Pertel T, Regev K, Griffin R, Aly L, Kivisakk P, Nejad P, Patel B, Gwanyalla N, Hei H, Glanz B, ... Chitnis T, et al. Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation. Journal of Neuroinflammation. 12: 245. PMID 26714756 DOI: 10.1186/s12974-015-0460-z |
0.6 |
|
| 2015 |
Chitnis T, Ness J, Krupp L, Waubant E, Hunt T, Olsen CS, Rodriguez M, Lotze T, Gorman M, Benson L, Belman A, Weinstock-Guttman B, Aaen G, Graves J, Patterson M, et al. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology. PMID 26683648 DOI: 10.1212/WNL.0000000000002283 |
0.6 |
|
| 2015 |
Chua AS, Glanz BI, Guarino AJ, Cook SL, Greeke EE, Little GE, Chitnis T, Healy BC. Patient-reported outcomes in multiple sclerosis: Relationships among existing scales and the development of a brief measure. Multiple Sclerosis and Related Disorders. 4: 598-606. PMID 26590669 DOI: 10.1016/j.msard.2015.09.004 |
0.6 |
|
| 2015 |
Xia Z, White CC, Owen EK, Von Korff A, Clarkson SR, McCabe CA, Cimpean M, Winn PA, Hoesing A, Steele SU, Cortese IC, Chitnis T, Weiner HL, Reich DS, Chibnik LB, et al. GEMS Project: A Platform to Investigate Multiple Sclerosis Risk. Annals of Neurology. PMID 26583565 DOI: 10.1002/ana.24560 |
0.6 |
|
| 2015 |
Rotstein DL, Healy BC, Malik MT, Carruthers RL, Musallam AJ, Kivisakk P, Weiner HL, Glanz B, Chitnis T. Effect of vitamin D on MS activity by disease-modifying therapy class. Neurology® Neuroimmunology & Neuroinflammation. 2: e167. PMID 26568968 DOI: 10.1212/NXI.0000000000000167 |
0.6 |
|
| 2015 |
Bove R, Healy BC, Musallam A, Glanz BI, De Jager PL, Chitnis T. Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26447063 DOI: 10.1177/1352458515606211 |
0.4 |
|
| 2015 |
Oommen VV, Tauhid S, Healy BC, Chua AS, Malik MT, Diaz-Cruz C, Dupuy SL, Weiner HL, Chitnis T, Bakshi R. The Effect of Fingolimod on Conversion of Acute Gadolinium-Enhancing Lesions to Chronic T1 Hypointensities in Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 26445919 DOI: 10.1111/jon.12307 |
0.6 |
|
| 2015 |
Bove R, Malik MT, Diaz-Cruz C, Chua A, Saraceno TJ, Bargiela D, Greeke E, Glanz BI, Healy BC, Chitnis T. The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS. Neurology. 85: 1209-13. PMID 26341868 DOI: 10.1212/WNL.0000000000001990 |
0.6 |
|
| 2015 |
Liu J, Brodley CE, Healy BC, Chitnis T. Removing confounding factors via constraint-based clustering: An application to finding homogeneous groups of multiple sclerosis patients. Artificial Intelligence in Medicine. PMID 26253753 DOI: 10.1016/j.artmed.2015.06.004 |
0.6 |
|
| 2015 |
Tauhid S, Chu R, Sasane R, Glanz BI, Neema M, Miller JR, Kim G, Signorovitch JE, Healy BC, Chitnis T, Weiner HL, Bakshi R. Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis. Journal of Neurology. PMID 26205635 DOI: 10.1007/s00415-015-7853-x |
0.6 |
|
| 2015 |
Chua AS, Egorova S, Anderson MC, Polgar-Turcsanyi M, Chitnis T, Weiner HL, Guttmann CR, Bakshi R, Healy BC. Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models. Neuroimage. Clinical. 8: 606-10. PMID 26199872 DOI: 10.1016/j.nicl.2015.06.009 |
0.52 |
|
| 2015 |
Chua AS, Egorova S, Anderson MC, Polgar-Turcsanyi M, Chitnis T, Weiner HL, Guttmann CR, Bakshi R, Healy BC. Using multiple imputation to efficiently correct cerebral MRI whole brain lesion and atrophy data in patients with multiple sclerosis. Neuroimage. PMID 26093330 DOI: 10.1016/j.neuroimage.2015.06.037 |
0.6 |
|
| 2015 |
Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 85: 177-89. PMID 26092914 DOI: 10.1212/WNL.0000000000001729 |
0.6 |
|
| 2015 |
Baruch NF, O'Donnell EH, Glanz BI, Benedict RH, Musallam AJ, Healy BC, Rintell D, Chitnis T. Cognitive and patient-reported outcomes in adults with pediatric-onset multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26041802 DOI: 10.1177/1352458515588781 |
0.6 |
|
| 2015 |
Fernandez-Carbonell C, Vargas-Lowy D, Musallam A, Healy B, McLaughlin K, Wucherpfennig KW, Chitnis T. Clinical and MRI phenotype of children with MOG antibodies. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26041801 DOI: 10.1177/1352458515587751 |
0.6 |
|
| 2015 |
Kremer S, Renard F, Achard S, Lana-Peixoto MA, Palace J, Asgari N, Klawiter EC, Tenembaum SN, Banwell B, Greenberg BM, Bennett JL, Levy M, Villoslada P, Saiz A, Fujihara K, ... ... Chitnis T, et al. Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder. Jama Neurology. 72: 815-22. PMID 26010909 DOI: 10.1001/jamaneurol.2015.0248 |
0.6 |
|
| 2015 |
Pandit L, Asgari N, Apiwattanakul M, Palace J, Paul F, Leite MI, Kleiter I, Chitnis T. Demographic and clinical features of neuromyelitis optica: A review. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 845-53. PMID 25921037 DOI: 10.1177/1352458515572406 |
0.6 |
|
| 2015 |
Bove R, Healy BC, Secor E, Vaughan T, Katic B, Chitnis T, Wicks P, De Jager PL. Patients report worse MS symptoms after menopause: findings from an online cohort. Multiple Sclerosis and Related Disorders. 4: 18-24. PMID 25787049 DOI: 10.1016/j.msard.2014.11.009 |
0.6 |
|
| 2015 |
Engler D, Chitnis T, Healy B. Joint assessment of dependent discrete disease state processes. Statistical Methods in Medical Research. PMID 25698716 DOI: 10.1177/0962280215569899 |
0.52 |
|
| 2015 |
Rotstein DL, Healy BC, Malik MT, Chitnis T, Weiner HL. Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort. Jama Neurology. 72: 152-8. PMID 25531931 DOI: 10.1001/jamaneurol.2014.3537 |
0.6 |
|
| 2015 |
Raghavan K, Healy BC, Carruthers RL, Chitnis T. Progression rates and sample size estimates for PPMS based on the CLIMB study population. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 180-8. PMID 25070676 DOI: 10.1177/1352458514541976 |
0.6 |
|
| 2015 |
Chua AS, Egorova S, Anderson MC, Polgar-Turcsanyi M, Chitnis T, Weiner HL, Guttmann CRG, Bakshi R, Healy BC. Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models Neuroimage: Clinical. 8: 606-610. DOI: 10.1016/j.nicl.2015.06.009 |
0.6 |
|
| 2014 |
Benson LA, Healy BC, Gorman MP, Baruch NF, Gholipour T, Musallam A, Chitnis T. Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years. Multiple Sclerosis and Related Disorders. 3: 186-93. PMID 25878006 DOI: 10.1016/j.msard.2013.06.004 |
0.6 |
|
| 2014 |
Chitnis T, Gorman MP. Impact of MS during the critical window of brain development. Neurology. 83: 2106-7. PMID 25378681 DOI: 10.1212/WNL.0000000000001056 |
0.6 |
|
| 2014 |
Graves J, Grandhe S, Weinfurtner K, Krupp L, Belman A, Chitnis T, Ness J, Weinstock-Guttman B, Gorman M, Patterson M, Rodriguez M, Lotze T, Aaen G, Mowry EM, Rose JW, et al. Protective environmental factors for neuromyelitis optica. Neurology. 83: 1923-9. PMID 25339213 DOI: 10.1212/WNL.0000000000001001 |
0.6 |
|
| 2014 |
Casper TC, Rose JW, Roalstad S, Waubant E, Aaen G, Belman A, Chitnis T, Gorman M, Krupp L, Lotze TE, Ness J, Patterson M, Rodriguez M, Weinstock-Guttman B, Browning B, et al. The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. Journal of Child Neurology. PMID 25270659 DOI: 10.1177/0883073814550656 |
0.6 |
|
| 2014 |
Bakshi R, Neema M, Tauhid S, Healy BC, Glanz BI, Kim G, Miller J, Berkowitz JL, Bove R, Houtchens MK, Severson C, Stankiewicz JM, Stazzone L, Chitnis T, Guttmann CR, et al. An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2. Neuroreport. 25: 1156-61. PMID 25100554 DOI: 10.1097/WNR.0000000000000244 |
0.6 |
|
| 2014 |
Glanz BI, Musallam A, Rintell DJ, Chitnis T, Weiner HL, Healy BC. Treatment satisfaction in multiple sclerosis. International Journal of Ms Care. 16: 68-75. PMID 25061430 DOI: 10.7224/1537-2073.2013-021 |
0.6 |
|
| 2014 |
Chitnis T, Waubant E. B-cell depletion in children with neuroimmunologic conditions: the learning curve. Neurology. 83: 111-2. PMID 24920852 DOI: 10.1212/WNL.0000000000000576 |
0.6 |
|
| 2014 |
Carruthers RL, Rotstein DL, Healy BC, Chitnis T, Weiner HL, Buckle GJ. An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1381-90. PMID 24852928 DOI: 10.1177/1352458514535282 |
0.6 |
|
| 2014 |
Malik MT, Healy BC, Benson LA, Kivisakk P, Musallam A, Weiner HL, Chitnis T. Factors associated with recovery from acute optic neuritis in patients with multiple sclerosis. Neurology. 82: 2173-9. PMID 24850491 DOI: 10.1212/WNL.0000000000000524 |
0.6 |
|
| 2014 |
Bove R, Musallam A, Healy BC, Raghavan K, Glanz BI, Bakshi R, Weiner H, De Jager PL, Miller KK, Chitnis T. Low testosterone is associated with disability in men with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1584-92. PMID 24710799 DOI: 10.1177/1352458514527864 |
0.6 |
|
| 2014 |
Charvet LE, O'Donnell EH, Belman AL, Chitnis T, Ness JM, Parrish J, Patterson M, Rodriguez M, Waubant E, Weinstock-Guttman B, Krupp LB. Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1502-10. PMID 24687807 DOI: 10.1177/1352458514527862 |
0.6 |
|
| 2014 |
Bove R, Chitnis T. The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 520-6. PMID 24561324 DOI: 10.1177/1352458513519181 |
0.6 |
|
| 2014 |
Linnoila J, Chitnis T. Balo concentric sclerosis in children: a case series. Journal of Child Neurology. 29: 603-7. PMID 24423690 DOI: 10.1177/0883073813517294 |
0.6 |
|
| 2014 |
Carruthers RL, Chitnis T, Healy BC. Modeling probability of additional cases of natalizumab-associated JCV sero-negative progressive multifocal leukoencephalopathy. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 757-60. PMID 24189572 DOI: 10.1177/1352458513509509 |
0.6 |
|
| 2014 |
Bove R, Chitnis T, Houtchens M. Menopause in multiple sclerosis: therapeutic considerations. Journal of Neurology. 261: 1257-68. PMID 24101131 DOI: 10.1007/s00415-013-7131-8 |
0.6 |
|
| 2014 |
Fernández Carbonell C, Benson L, Rintell D, Prince J, Chitnis T. Functional relapses in pediatric multiple sclerosis. Journal of Child Neurology. 29: 943-6. PMID 24065582 DOI: 10.1177/0883073813501873 |
0.6 |
|
| 2014 |
Kivisäkk P, Healy BC, Francois K, Gandhi R, Gholipour T, Egorova S, Sevdalinova V, Quintana F, Chitnis T, Weiner HL, Khoury SJ. Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 438-44. PMID 24005026 DOI: 10.1177/1352458513503052 |
0.6 |
|
| 2013 |
Xia Z, Secor E, Chibnik LB, Bove RM, Cheng S, Chitnis T, Cagan A, Gainer VS, Chen PJ, Liao KP, Shaw SY, Ananthakrishnan AN, Szolovits P, Weiner HL, Karlson EW, et al. Modeling disease severity in multiple sclerosis using electronic health records. Plos One. 8: e78927. PMID 24244385 DOI: 10.1371/journal.pone.0078927 |
0.6 |
|
| 2013 |
Chitnis T, Guttmann CR, Zaitsev A, Musallam A, Weinstock-Guttman B, Yeh A, Rodriguez M, Ness J, Gorman MP, Healy BC, Kuntz N, Chabas D, Strober JB, Waubant E, Krupp L, et al. Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study. Bmc Neurology. 13: 173. PMID 24225378 DOI: 10.1186/1471-2377-13-173 |
0.6 |
|
| 2013 |
Messina S, Vargas-Lowy D, Musallam A, Healy BC, Kivisakk P, Gandhi R, Bove R, Gholipour T, Khoury S, Weiner HL, Chitnis T. Increased leptin and A-FABP levels in relapsing and progressive forms of MS. Bmc Neurology. 13: 172. PMID 24215402 DOI: 10.1186/1471-2377-13-172 |
0.6 |
|
| 2013 |
Ottoboni L, Frohlich IY, Lee M, Healy BC, Keenan BT, Xia Z, Chitnis T, Guttmann CR, Khoury SJ, Weiner HL, Hafler DA, De Jager PL. Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus. Neurology. 81: 1891-9. PMID 24174586 DOI: 10.1212/01.wnl.0000436612.66328.8a |
0.6 |
|
| 2013 |
Chitnis T, Khoury SJ. Sex influences in autoimmune disease. Clinical Immunology (Orlando, Fla.). 149: 169. PMID 24012474 DOI: 10.1016/j.clim.2013.08.002 |
0.6 |
|
| 2013 |
Chitnis T. Paediatric MS is the same disease as adult MS: no. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1255-6. PMID 23996596 DOI: 10.1177/1352458513488842 |
0.6 |
|
| 2013 |
Chitnis T. Pediatric demyelinating diseases. Continuum (Minneapolis, Minn.). 19: 1023-45. PMID 23917099 DOI: 10.1212/01.CON.0000433285.84973.43 |
0.6 |
|
| 2013 |
Bove R, Musallam A, Healy BC, Houtchens M, Glanz BI, Khoury S, Guttmann CR, De Jager PL, Chitnis T. No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50. Bmc Neurology. 13: 73. PMID 23822612 DOI: 10.1186/1471-2377-13-73 |
0.6 |
|
| 2013 |
Fernández Carbonell C, Chitnis T. Inflammatory demyelinating diseases in children: an update. Minerva Pediatrica. 65: 307-23. PMID 23685382 |
0.6 |
|
| 2013 |
Chitnis T. Role of puberty in multiple sclerosis risk and course. Clinical Immunology (Orlando, Fla.). 149: 192-200. PMID 23623473 DOI: 10.1016/j.clim.2013.03.014 |
0.6 |
|
| 2013 |
Van Haren K, Tomooka BH, Kidd BA, Banwell B, Bar-Or A, Chitnis T, Tenembaum SN, Pohl D, Rostasy K, Dale RC, O'Connor KC, Hafler DA, Steinman L, Robinson WH. Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1726-33. PMID 23612879 DOI: 10.1177/1352458513485653 |
0.6 |
|
| 2013 |
Bove R, Chitnis T. Sexual disparities in the incidence and course of MS. Clinical Immunology (Orlando, Fla.). 149: 201-10. PMID 23608496 DOI: 10.1016/j.clim.2013.03.005 |
0.6 |
|
| 2013 |
Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, Ghezzi A, Hintzen R, Kornberg A, Pohl D, Rostasy K, Tenembaum S, Wassmer E. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1261-7. PMID 23572237 DOI: 10.1177/1352458513484547 |
0.6 |
|
| 2013 |
Healy BC, Engler D, Glanz B, Musallam A, Chitnis T. Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis. Multiple Sclerosis International. 2013: 189624. PMID 23555057 DOI: 10.1155/2013/189624 |
0.4 |
|
| 2013 |
Bove R, Secor E, Healy BC, Musallam A, Vaughan T, Glanz BI, Greeke E, Weiner HL, Chitnis T, Wicks P, De Jager PL. Evaluation of an online platform for multiple sclerosis research: patient description, validation of severity scale, and exploration of BMI effects on disease course. Plos One. 8: e59707. PMID 23527256 DOI: 10.1371/journal.pone.0059707 |
0.6 |
|
| 2013 |
Chitnis T, Tardieu M, Amato MP, Banwell B, Bar-Or A, Ghezzi A, Kornberg A, Krupp LB, Pohl D, Rostasy K, Tenembaum S, Waubant E, Wassmer E. International Pediatric MS Study Group Clinical Trials Summit: meeting report. Neurology. 80: 1161-8. PMID 23509048 DOI: 10.1212/WNL.0b013e318288694e |
0.6 |
|
| 2013 |
Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS, Nejad P, Patel B, Hei H, Khoury S, Quintana F, Kivisakk P, Chitnis T, Weiner HL. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Annals of Neurology. 73: 729-40. PMID 23494648 DOI: 10.1002/ana.23880 |
0.6 |
|
| 2013 |
Vargas-Lowy D, Kivisäkk P, Gandhi R, Raddassi K, Soltany P, Gorman MP, Khoury SJ, Chitnis T. Increased Th17 response to myelin peptides in pediatric MS. Clinical Immunology (Orlando, Fla.). 146: 176-84. PMID 23352968 DOI: 10.1016/j.clim.2012.12.008 |
0.6 |
|
| 2013 |
Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, James JA. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 891-5. PMID 23232601 DOI: 10.1177/1352458512469693 |
0.6 |
|
| 2013 |
Chitnis T. Disease-modifying therapy of pediatric multiple sclerosis. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 10: 89-96. PMID 23224690 DOI: 10.1007/s13311-012-0158-1 |
0.6 |
|
| 2013 |
Julian L, Serafin D, Charvet L, Ackerson J, Benedict R, Braaten E, Brown T, O'Donnell E, Parrish J, Preston T, Zaccariello M, Belman A, Chitnis T, Gorman M, Ness J, et al. Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. Journal of Child Neurology. 28: 102-7. PMID 23155206 DOI: 10.1177/0883073812464816 |
0.6 |
|
| 2013 |
Vishwas MS, Healy BC, Pienaar R, Gorman MP, Grant PE, Chitnis T. Diffusion tensor analysis of pediatric multiple sclerosis and clinically isolated syndromes. Ajnr. American Journal of Neuroradiology. 34: 417-23. PMID 22859275 DOI: 10.3174/ajnr.A3216 |
0.6 |
|
| 2013 |
Liu J, Brodley CE, Healy BC, Chitnis T. Removing confounding factors via constraint based clustering: An application to finding homogeneous groups of multiple sclerosis patients Proceedings - 2013 Ieee International Conference On Healthcare Informatics, Ichi 2013. 487-492. DOI: 10.1109/ICHI.2013.75 |
0.6 |
|
| 2012 |
Glanz BI, Dégano IR, Rintell DJ, Chitnis T, Weiner HL, Healy BC. Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 15: 1029-35. PMID 23244804 DOI: 10.1016/j.jval.2012.07.010 |
0.6 |
|
| 2012 |
Vargas-Lowy D, Chitnis T. Pathogenesis of pediatric multiple sclerosis. Journal of Child Neurology. 27: 1394-407. PMID 22952316 DOI: 10.1177/0883073812456084 |
0.6 |
|
| 2012 |
Ceccarelli A, Jackson JS, Tauhid S, Arora A, Gorky J, Dell'Oglio E, Bakshi A, Chitnis T, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R, Neema M. The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosis. Ajnr. American Journal of Neuroradiology. 33: 1579-85. PMID 22460341 DOI: 10.3174/ajnr.A3083 |
0.6 |
|
| 2012 |
Bove RM, Healy B, Augustine A, Musallam A, Gholipour T, Chitnis T. Effect of gender on late-onset multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1472-9. PMID 22383227 DOI: 10.1177/1352458512438236 |
0.6 |
|
| 2012 |
Healy BC, Degano IR, Schreck A, Rintell D, Weiner H, Chitnis T, Glanz BI. The impact of a recent relapse on patient-reported outcomes in subjects with multiple sclerosis. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 21: 1677-84. PMID 22237991 DOI: 10.1007/s11136-011-0108-0 |
0.6 |
|
| 2012 |
Gorman MP, Tillema JM, Ciliax AM, Guttmann CR, Chitnis T. Daclizumab use in patients with pediatric multiple sclerosis. Archives of Neurology. 69: 78-81. PMID 22232346 DOI: 10.1001/archneurol.2011.581 |
0.6 |
|
| 2012 |
Chitnis T, Hollmann TJ. CADASIL mutation and Balo concentric sclerosis: a link between demyelination and ischemia? Neurology. 78: 221-3. PMID 22218279 DOI: 10.1212/WNL.0b013e31823fcd3c |
0.6 |
|
| 2012 |
Moodie J, Healy BC, Buckle GJ, Gauthier SA, Glanz BI, Arora A, Ceccarelli A, Tauhid S, Han XM, Venkataraman A, Chitnis T, Khoury SJ, Guttmann CR, Weiner HL, Neema M, et al. Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: a longitudinal study. Journal of the Neurological Sciences. 315: 49-54. PMID 22209496 DOI: 10.1016/j.jns.2011.11.040 |
0.6 |
|
| 2012 |
Chitnis T, Tenembaum S, Banwell B, Krupp L, Pohl D, Rostasy K, Yeh EA, Bykova O, Wassmer E, Tardieu M, Kornberg A, Ghezzi A. Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 116-27. PMID 22146610 DOI: 10.1177/1352458511430704 |
0.6 |
|
| 2012 |
Glanz BI, Healy BC, Hviid LE, Chitnis T, Weiner HL. Cognitive deterioration in patients with early multiple sclerosis: a 5-year study. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 38-43. PMID 21746743 DOI: 10.1136/jnnp.2010.237834 |
0.6 |
|
| 2012 |
Chitnis T. Pediatric Multiple Sclerosis and Acute Disseminated Encephalomyelitis Multiple Sclerosis: Diagnosis and Therapy. 101-135. DOI: 10.1002/9781119963714.ch5 |
0.6 |
|
| 2011 |
Mirzaei F, Michels KB, Munger K, O'Reilly E, Chitnis T, Forman MR, Giovannucci E, Rosner B, Ascherio A. Gestational vitamin D and the risk of multiple sclerosis in offspring. Annals of Neurology. 70: 30-40. PMID 21786297 DOI: 10.1002/ana.22456 |
0.6 |
|
| 2011 |
Gholipour T, Healy B, Baruch NF, Weiner HL, Chitnis T. Demographic and clinical characteristics of malignant multiple sclerosis. Neurology. 76: 1996-2001. PMID 21646626 DOI: 10.1212/WNL.0b013e31821e559d |
0.6 |
|
| 2011 |
Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Chabas D, Strober J, McDonald J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, et al. Common viruses associated with lower pediatric multiple sclerosis risk. Neurology. 76: 1989-95. PMID 21646624 DOI: 10.1212/WNL.0b013e31821e552a |
0.6 |
|
| 2011 |
Healy B, Chitnis T, Engler D. Improving power to detect disease progression in multiple sclerosis through alternative analysis strategies. Journal of Neurology. 258: 1812-9. PMID 21472497 DOI: 10.1007/s00415-011-6021-1 |
0.6 |
|
| 2011 |
Chitnis T, Krupp L, Yeh A, Rubin J, Kuntz N, Strober JB, Chabas D, Weinstock-Guttmann B, Ness J, Rodriguez M, Waubant E. Pediatric multiple sclerosis. Neurologic Clinics. 29: 481-505. PMID 21439455 DOI: 10.1016/j.ncl.2011.01.004 |
0.6 |
|
| 2011 |
Liguori M, Meier DS, Hildenbrand P, Healy BC, Chitnis T, Baruch NF, Khoury SJ, Weiner HL, Bakshi R, Barkhof F, Guttmann CR. One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 1125-31. PMID 21429902 DOI: 10.1136/jnnp.2011.242115 |
0.6 |
|
| 2011 |
Hviid LE, Healy BC, Rintell DJ, Chitnis T, Weiner HL, Glanz BI. Patient reported outcomes in benign multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 876-84. PMID 21372114 DOI: 10.1177/1352458511398370 |
0.6 |
|
| 2011 |
Imitola J, Côté D, Rasmussen S, Xie XS, Liu Y, Chitnis T, Sidman RL, Lin CP, Khoury SJ. Multimodal coherent anti-Stokes Raman scattering microscopy reveals microglia-associated myelin and axonal dysfunction in multiple sclerosis-like lesions in mice. Journal of Biomedical Optics. 16: 021109. PMID 21361672 DOI: 10.1117/1.3533312 |
0.6 |
|
| 2011 |
Healy BC, Engler D, Gholipour T, Weiner H, Bakshi R, Chitnis T. Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis. Journal of the Neurological Sciences. 303: 109-13. PMID 21251671 DOI: 10.1016/j.jns.2010.12.024 |
0.6 |
|
| 2011 |
Yeh EA, Waubant E, Krupp LB, Ness J, Chitnis T, Kuntz N, Ramanathan M, Belman A, Chabas D, Gorman MP, Rodriguez M, Rinker JR, Weinstock-Guttman B. Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis. Archives of Neurology. 68: 437-44. PMID 21149803 DOI: 10.1001/archneurol.2010.325 |
0.6 |
|
| 2011 |
Gross R, Healy BC, Cepok S, Chitnis T, Khoury SJ, Hemmer B, Weiner HL, Hafler DA, De Jager PL. Population structure and HLA DRB1 1501 in the response of subjects with multiple sclerosis to first-line treatments. Journal of Neuroimmunology. 233: 168-74. PMID 21115201 DOI: 10.1016/j.jneuroim.2010.10.038 |
0.6 |
|
| 2011 |
Munger KL, Chitnis T, Frazier AL, Giovannucci E, Spiegelman D, Ascherio A. Dietary intake of vitamin D during adolescence and risk of multiple sclerosis. Journal of Neurology. 258: 479-85. PMID 20945071 DOI: 10.1007/s00415-010-5783-1 |
0.6 |
|
| 2011 |
Chitnis T, Khoury SJ. T-cell-based therapies for multiple sclerosis Multiple Sclerosis Therapeutics, Fourth Edition. 472-482. DOI: 10.1017/CBO9781139023986.044 |
0.6 |
|
| 2011 |
Chitnis T, Bar-Or A. Pediatric MS: Biological presentation and research update Demyelinating Disorders of the Central Nervous System in Childhood. 157-168. DOI: 10.1017/CBO9780511974373.016 |
0.6 |
|
| 2010 |
Xia Z, Chibnik LB, Glanz BI, Liguori M, Shulman JM, Tran D, Khoury SJ, Chitnis T, Holyoak T, Weiner HL, Guttmann CR, De Jager PL. A putative Alzheimer's disease risk allele in PCK1 influences brain atrophy in multiple sclerosis. Plos One. 5: e14169. PMID 21152065 DOI: 10.1371/journal.pone.0014169 |
0.6 |
|
| 2010 |
Healy BC, Glanz BI, Stankiewicz J, Buckle G, Weiner H, Chitnis T. A method for evaluating treatment switching criteria in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 1483-9. PMID 20736245 DOI: 10.1177/1352458510379245 |
0.6 |
|
| 2010 |
Healy BC, Liguori M, Tran D, Chitnis T, Glanz B, Wolfish C, Gauthier S, Buckle G, Houtchens M, Stazzone L, Khoury S, Hartzmann R, Fernandez-Vina M, Hafler DA, Weiner HL, et al. HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology. 75: 634-40. PMID 20713950 DOI: 10.1212/WNL.0b013e3181ed9c9c |
0.6 |
|
| 2010 |
Kuntz NL, Chabas D, Weinstock-Guttman B, Chitnis T, Yeh EA, Krupp L, Ness J, Rodriguez M, Waubant E. Treatment of multiple sclerosis in children and adolescents. Expert Opinion On Pharmacotherapy. 11: 505-20. PMID 20163265 DOI: 10.1517/14656560903527218 |
0.6 |
|
| 2010 |
Liu Y, Bando Y, Vargas-Lowy D, Elyaman W, Khoury SJ, Huang T, Reif K, Chitnis T. CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 2025-38. PMID 20147531 DOI: 10.1523/JNEUROSCI.4272-09.2010 |
0.6 |
|
| 2010 |
Chabas D, Ness J, Belman A, Yeh EA, Kuntz N, Gorman MP, Strober JB, De Kouchkovsky I, McCulloch C, Chitnis T, Rodriguez M, Weinstock-Guttman B, Krupp LB, Waubant E. Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology. 74: 399-405. PMID 20124205 DOI: 10.1212/WNL.0b013e3181ce5db0 |
0.6 |
|
| 2010 |
Vishwas MS, Chitnis T, Pienaar R, Healy BC, Grant PE. Tract-based analysis of callosal, projection, and association pathways in pediatric patients with multiple sclerosis: a preliminary study. Ajnr. American Journal of Neuroradiology. 31: 121-8. PMID 19850763 DOI: 10.3174/ajnr.A1776 |
0.6 |
|
| 2009 |
Munger KL, Chitnis T, Ascherio A. Body size and risk of MS in two cohorts of US women. Neurology. 73: 1543-50. PMID 19901245 DOI: 10.1212/WNL.0b013e3181c0d6e0 |
0.6 |
|
| 2009 |
Yeh EA, Chitnis T, Krupp L, Ness J, Chabas D, Kuntz N, Waubant E. Pediatric multiple sclerosis. Nature Reviews. Neurology. 5: 621-31. PMID 19826402 DOI: 10.1038/nrneurol.2009.158 |
0.6 |
|
| 2009 |
Sampat MP, Berger AM, Healy BC, Hildenbrand P, Vass J, Meier DS, Chitnis T, Weiner HL, Bakshi R, Guttmann CR. Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data. Ajnr. American Journal of Neuroradiology. 30: 1731-9. PMID 19696139 DOI: 10.3174/ajnr.A1659 |
0.6 |
|
| 2009 |
McLaughlin KA, Chitnis T, Newcombe J, Franz B, Kennedy J, McArdel S, Kuhle J, Kappos L, Rostasy K, Pohl D, Gagne D, Ness JM, Tenembaum S, O'Connor KC, Viglietta V, et al. Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 183: 4067-76. PMID 19687098 DOI: 10.4049/jimmunol.0801888 |
0.6 |
|
| 2009 |
Healy BC, Ali EN, Guttmann CR, Chitnis T, Glanz BI, Buckle G, Houtchens M, Stazzone L, Moodie J, Berger AM, Duan Y, Bakshi R, Khoury S, Weiner H, Ascherio A. Smoking and disease progression in multiple sclerosis. Archives of Neurology. 66: 858-64. PMID 19597087 DOI: 10.1001/archneurol.2009.122 |
0.6 |
|
| 2009 |
Makhani N, Gorman MP, Branson HM, Stazzone L, Banwell BL, Chitnis T. Cyclophosphamide therapy in pediatric multiple sclerosis. Neurology. 72: 2076-82. PMID 19439723 DOI: 10.1212/WNL.0b013e3181a8164c |
0.6 |
|
| 2009 |
Gardener H, Munger K, Chitnis T, Spiegelman D, Ascherio A. The relationship between handedness and risk of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 587-92. PMID 19389750 DOI: 10.1177/1352458509102622 |
0.6 |
|
| 2009 |
Gardener H, Munger KL, Chitnis T, Michels KB, Spiegelman D, Ascherio A. Prenatal and perinatal factors and risk of multiple sclerosis. Epidemiology (Cambridge, Mass.). 20: 611-8. PMID 19333127 DOI: 10.1097/EDE.0b013e31819ed4b9 |
0.6 |
|
| 2009 |
Chitnis T, Glanz B, Jaffin S, Healy B. Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 627-31. PMID 19299440 DOI: 10.1177/1352458508101933 |
0.6 |
|
| 2009 |
Chitnis T, Pirko I. Sensitivity vs specificity: progress and pitfalls in defining MRI criteria for pediatric MS. Neurology. 72: 952-3. PMID 19289735 DOI: 10.1212/01.wnl.0000344414.57976.97 |
0.6 |
|
| 2009 |
Stankiewicz JM, Neema M, Alsop DC, Healy BC, Arora A, Buckle GJ, Chitnis T, Guttmann CR, Hackney D, Bakshi R. Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study. Journal of the Neurological Sciences. 279: 99-105. PMID 19178916 DOI: 10.1016/j.jns.2008.11.009 |
0.6 |
|
| 2009 |
Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Archives of Neurology. 66: 54-9. PMID 19139299 DOI: 10.1001/archneurol.2008.505 |
0.6 |
|
| 2009 |
Wang Y, Evans JT, Rodriguez F, Fields P, Mueller C, Chitnis T, Khoury SJ, Bynoe MS. A tale of two STAT6 knock out mice in the induction of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 206: 76-85. PMID 19100630 DOI: 10.1016/j.jneuroim.2008.11.003 |
0.6 |
|
| 2008 |
Elyaman W, Kivisäkk P, Reddy J, Chitnis T, Raddassi K, Imitola J, Bradshaw E, Kuchroo VK, Yagita H, Sayegh MH, Khoury SJ. Distinct functions of autoreactive memory and effector CD4+ T cells in experimental autoimmune encephalomyelitis. The American Journal of Pathology. 173: 411-22. PMID 18583313 DOI: 10.2353/ajpath.2008.080142 |
0.6 |
|
| 2007 |
Chitnis T. The role of CD4 T cells in the pathogenesis of multiple sclerosis. International Review of Neurobiology. 79: 43-72. PMID 17531837 DOI: 10.1016/S0074-7742(07)79003-7 |
0.6 |
|
| 2007 |
Chitnis T, Imitola J, Wang Y, Elyaman W, Chawla P, Sharuk M, Raddassi K, Bronson RT, Khoury SJ. Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration. The American Journal of Pathology. 170: 1695-712. PMID 17456775 DOI: 10.2353/ajpath.2007.060677 |
0.6 |
|
| 2007 |
Belman AL, Chitnis T, Renoux C, Waubant E. Challenges in the classification of pediatric multiple sclerosis and future directions. Neurology. 68: S70-4. PMID 17438242 DOI: 10.1212/01.wnl.0000259421.40556.76 |
0.6 |
|
| 2007 |
Pohl D, Waubant E, Banwell B, Chabas D, Chitnis T, Weinstock-Guttman B, Tenembaum S. Treatment of pediatric multiple sclerosis and variants. Neurology. 68: S54-65. PMID 17438239 DOI: 10.1212/01.wnl.0000259407.40023.ab |
0.6 |
|
| 2007 |
Tenembaum S, Chitnis T, Ness J, Hahn JS. Acute disseminated encephalomyelitis. Neurology. 68: S23-36. PMID 17438235 DOI: 10.1212/01.wnl.0000259404.51352.7f |
0.6 |
|
| 2007 |
O'Connor KC, McLaughlin KA, De Jager PL, Chitnis T, Bettelli E, Xu C, Robinson WH, Cherry SV, Bar-Or A, Banwell B, Fukaura H, Fukazawa T, Tenembaum S, Wong SJ, Tavakoli NP, et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nature Medicine. 13: 211-7. PMID 17237795 DOI: 10.1038/nm1488 |
0.6 |
|
| 2006 |
Chitnis T. Pediatric multiple sclerosis. The Neurologist. 12: 299-310. PMID 17122726 DOI: 10.1097/01.nrl.0000250946.87145.cf |
0.6 |
|
| 2006 |
Kaneko S, Wang J, Kaneko M, Yiu G, Hurrell JM, Chitnis T, Khoury SJ, He Z. Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 9794-804. PMID 16988050 DOI: 10.1523/JNEUROSCI.2116-06.2006 |
0.6 |
|
| 2006 |
Zhu B, Guleria I, Khosroshahi A, Chitnis T, Imitola J, Azuma M, Yagita H, Sayegh MH, Khoury SJ. Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 176: 3480-9. PMID 16517716 |
0.6 |
|
| 2006 |
Imitola J, Chitnis T, Khoury SJ. Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implications for future therapies. Archives of Neurology. 63: 25-33. PMID 16401734 DOI: 10.1001/archneur.63.1.25 |
0.6 |
|
| 2005 |
Imitola J, Chitnis T, Khoury SJ. Cytokines in multiple sclerosis: from bench to bedside. Pharmacology & Therapeutics. 106: 163-77. PMID 15866318 DOI: 10.1016/j.pharmthera.2004.11.007 |
0.6 |
|
| 2005 |
Chitnis T, Imitola J, Khoury SJ. Therapeutic strategies to prevent neurodegeneration and promote regeneration in multiple sclerosis. Current Drug Targets. Immune, Endocrine and Metabolic Disorders. 5: 11-26. PMID 15777201 DOI: 10.2174/1568008053174804 |
0.6 |
|
| 2004 |
Holsti MA, Chitnis T, Panzo RJ, Bronson RT, Yagita H, Sayegh MH, Tzianabos AO. Regulation of postsurgical fibrosis by the programmed death-1 inhibitory pathway. Journal of Immunology (Baltimore, Md. : 1950). 172: 5774-81. PMID 15100324 |
0.6 |
|
| 2004 |
Chitnis T, Salama AD, Grusby MJ, Sayegh MH, Khoury SJ. Defining Th1 and Th2 immune responses in a reciprocal cytokine environment in vivo. Journal of Immunology (Baltimore, Md. : 1950). 172: 4260-5. PMID 15034039 |
0.6 |
|
| 2003 |
Chitnis T, Khoury SJ. Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis. Immunologic Research. 28: 223-39. PMID 14713716 DOI: 10.1385/IR:28:3:223 |
0.6 |
|
| 2003 |
Chitnis T, Khoury SJ. Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. The Journal of Allergy and Clinical Immunology. 112: 837-49; quiz 850. PMID 14610467 DOI: 10.1016/j.jaci.2003.08.025 |
0.6 |
|
| 2003 |
Najafian N, Chitnis T, Salama AD, Zhu B, Benou C, Yuan X, Clarkson MR, Sayegh MH, Khoury SJ. Regulatory functions of CD8+CD28- T cells in an autoimmune disease model. The Journal of Clinical Investigation. 112: 1037-48. PMID 14523041 DOI: 10.1172/JCI17935 |
0.6 |
|
| 2003 |
Salama AD, Chitnis T, Imitola J, Ansari MJ, Akiba H, Tushima F, Azuma M, Yagita H, Sayegh MH, Khoury SJ. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. The Journal of Experimental Medicine. 198: 71-8. PMID 12847138 DOI: 10.1084/jem.20022119 |
0.6 |
|
| 2003 |
Ansari MJ, Salama AD, Chitnis T, Smith RN, Yagita H, Akiba H, Yamazaki T, Azuma M, Iwai H, Khoury SJ, Auchincloss H, Sayegh MH. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. The Journal of Experimental Medicine. 198: 63-9. PMID 12847137 DOI: 10.1084/jem.20022125 |
0.6 |
|
| 2003 |
Murphy B, Yu J, Jiao Q, Lin M, Chitnis T, Sayegh MH. A novel mechanism for the immunomodulatory functions of class II MHC-derived peptides. Journal of the American Society of Nephrology : Jasn. 14: 1053-65. PMID 12660341 DOI: 10.1097/01.ASN.0000057541.69641.F8 |
0.6 |
|
| 2003 |
O'Connor KC, Chitnis T, Griffin DE, Piyasirisilp S, Bar-Or A, Khoury S, Wucherpfennig KW, Hafler DA. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions. Journal of Neuroimmunology. 136: 140-8. PMID 12620653 DOI: 10.1016/S0165-5728(03)00002-X |
0.6 |
|
| 2003 |
Chitnis T, Khoury SJ. 20. Immunologic neuromuscular disorders. The Journal of Allergy and Clinical Immunology. 111: S659-68. PMID 12592311 |
0.6 |
|
| 2002 |
Chung DR, Chitnis T, Panzo RJ, Kasper DL, Sayegh MH, Tzianabos AO. CD4+ T cells regulate surgical and postinfectious adhesion formation. The Journal of Experimental Medicine. 195: 1471-8. PMID 12045245 DOI: 10.1084/jem.20020028 |
0.6 |
|
| 2001 |
Chitnis T, Najafian N, Benou C, Salama AD, Grusby MJ, Sayegh MH, Khoury SJ. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 108: 739-47. PMID 11544280 DOI: 10.1172/JCI12563 |
0.6 |
|
| 2001 |
Chitnis T, Najafian N, Abdallah KA, Dong V, Yagita H, Sayegh MH, Khoury SJ. CD28-independent induction of experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 107: 575-83. PMID 11238558 DOI: 10.1172/JCI11220 |
0.6 |
|
| 2000 |
Issazadeh S, Abdallah K, Chitnis T, Chandraker A, Wells AD, Turka LA, Sayegh MH, Khoury SJ. Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 105: 1109-16. PMID 10772655 DOI: 10.1172/JCI8607 |
0.6 |
|
| Show low-probability matches. |